Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome
PHASE1
Background:
Adult T-cell leukemia/lymphoma (ATLL) and mycosis fungoides/Se...
Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer
PHASE1
This phase I trial studies the side effects and best dose of recombinant in...
QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy
PHASE1
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy
PHASE1
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy
PHASE1
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...